Farallon Capital Management »

Sage Therapeutics shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $881k 43k 20.58
2021-03-31 $26M 345k 74.85
2020-12-31 $91M 1.1M 86.51
2020-09-30 $64M 1.1M 61.12
2020-06-30 $35M 850k 41.58
2020-03-31 $19M 675k 28.72
2019-12-31 $36M 500k 72.19
2019-09-30 $52M 373k 140.29
2019-06-30 $92M 500k 183.09
2019-03-31 $95M 600k 159.05
2018-12-31 $38M 400k 95.79
2018-09-30 $88M 625k 141.25
2018-06-30 $98M 625k 156.53
2018-03-31 $72M 445k 161.07
2017-12-31 $66M 400k 164.71
2017-09-30 $15M 244k 62.30
2017-06-30 $8.0M 100k 79.64